U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Gene sequence induced in skin by retinoids

Patent 5650279 Issued on July 22, 1997. Estimated Expiration Date: Icon_subject January 27, 2015. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.

Inventors

Application

No. 379280 filed on 01/27/1995

US Classes:

435/6, Involving nucleic acid435/91.2, Acellular exponential or geometric amplification (e.g., PCR, etc.)536/23.1, DNA or RNA fragments or modified forms thereof (e.g., genes, etc.)536/24.3, Probes for detection of specific nucleotide sequences or primers for the synthesis of DNA or RNA536/24.33Primers

Examiners

Primary: Jones, W. Gary
Assistant: Rees, Dianne

Attorney, Agent or Firm

International Classes

C12Q 001/68
C12P 019/34
C07H 021/02
C07H 021/04

Abstract

One aspect of the invention relates to a novel human cDNA, called TIG1 (Tazarotene Induced Gene 1). Expression of the corresponding TIG1 mRNA is strongly induced from a low basal level upon treatment of skin raft cultures with the RAR ଲ/γ selective anti-psoriatic synthetic retinoid AGN-190168 (ethyl 6-[2-(4,4) dimethyl-thiochroman-6-yl] ethynyl-nicotinate). The TIG1 mRNA is also up-regulated by AGN-190168 and the acid form AGN-190299 (6-[2-(4,4) dimethyl-thiochroman-6-yl] ethynyl-nicotinic acid) in skin raft cultures prepared from psoriatic fibroblasts and normal keratinocytes. Further, the TIG1 mRNA is similarly up-regulated by AGN-190168 in primary fibroblast and keratinocyte cultures. The low basal expression of the TIG1 mRNA is particularly advantageous when used as an indicator of retinoid action in psoriatic skin culture systems. Assay systems employing this unique TIG1 expression profile are disclosed.

Other References

  • Breathnach, S.M. Clin Exp Immunol. 91:343-345, 1993
  • Meinkoth, J. and Wahl G., Analytical Biochemistry 138:267-284, 1984
  • Durand, B., et al Cell 71: 73-85, 1992
  • Elder, J.T. et al J. Toxicol. Cut and Ocular Toxicol 12(2) 173-181 (1993)
  • Elder J.T et al J. of Investigative Dermatology 100(4):356-359, 1993
  • Jackson, D.G. et al. J. of Immunology 144:2811-2815, 1990
  • Kapp, A., J. of Dermatological Science 5:133-142, 1993
  • Li, et al Biotechniques 16: 722-729, 1994
  • Malvasi, F. et al. Immunology Today 15: 95-97, 1994
  • Magelsdorf, D.J. et al. The Retinoids, Chemistry and Medicine, 2nd edition, Ed. by M.B. Sport, A.B. Roberts and D.S. Goodman Raven, Press, N.Y. 1994 pp. 319-350
  • Nagpal, S. et al. Cell 70:1007-1019, 199
PatentsPlus Images
Enhanced PDF formats
loading...
PatentsPlus: add to cart
PatentsPlus: add to cartSearch-enhanced full patent PDF image
$9.95more info
 
Sign InRegister
Username  
Password   
forgot password?